AAAAAA
Results: 1-25/27
Authors:
Shakir, S
Pearce, G
Mann, RD
Citation: S. Shakir et al., Finasteride and tamsulosin used in benign prostatic hypertrophy: a review of the prescription-event monitoring data, BJU INT, 87(9), 2001, pp. 789-796
Authors:
Emerson, A
Martin, RM
Tomlin, M
Mann, RD
Citation: A. Emerson et al., Prospective cohort study of adverse events monitored by hospital pharmacists, PHARMA D S, 10(2), 2001, pp. 95-103
Authors:
Mann, RD
Citation: Rd. Mann, A celebration of the contributions of Martin Vessey, PHARMA D S, 10(1), 2001, pp. 1-1
Authors:
Mann, RD
Biswas, P
Freemantle, S
Pearce, G
Wilton, L
Citation: Rd. Mann et al., The pharmacovigilance of tamsulosin: event data on 12 484 patients, BJU INT, 85(4), 2000, pp. 446-450
Authors:
Mann, RD
Citation: Rd. Mann, The background to changing consent requirements regarding the use of recorded data for drug safety surveillance, PHARMA D S, 9(3), 2000, pp. 181-186
Authors:
Mann, RD
Pearce, GL
Dunn, N
Shakir, S
Citation: Rd. Mann et al., Sedation with "non-sedating'' antihistamines: four prescription-event monitoring studies in general practice, BR MED J, 320(7243), 2000, pp. 1184-1186
Authors:
Martin, RM
Biswas, P
Mann, RD
Citation: Rm. Martin et al., The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19087 patients in generalpractice in England: cohort study, BR J CL PH, 50(1), 2000, pp. 35-42
Authors:
Dunn, NR
Arscott, A
Thorogood, M
Faragher, B
de Caestecker, L
MacDonald, TM
McCollum, C
Thomas, S
Mann, RD
Citation: Nr. Dunn et al., Regional variation in incidence and case fatality of myocardial infarctionamong young women in England, Scotland and Wales, J EPIDEM C, 54(4), 2000, pp. 293-298
Authors:
Dunn, NR
Arscott, A
Mann, RD
Citation: Nr. Dunn et al., Costs of seeking ethics approval before and after the introduction of multicentre research ethics committees, J ROY S MED, 93(10), 2000, pp. 511-512
Authors:
Martin, RM
Rink, E
Wilkinson, DG
Mann, RD
Citation: Rm. Martin et al., Did knowledge, opinions, background, and health authority advice influenceearly prescribing of the novel Alzheimer's disease drug donepezil in general practice? National postal survey, PHARMA D S, 8(6), 1999, pp. 413-422
Authors:
Mann, RD
Citation: Rd. Mann, Data privacy and confidentiality, PHARMA D S, 8(4), 1999, pp. 245-245
Authors:
Mann, RD
Bertelsmann, A
Citation: Rd. Mann et A. Bertelsmann, The issue of data privacy and confidentiality in Europe - 1998, PHARMA D S, 8(4), 1999, pp. 261-264
Authors:
Mackay, FJ
Pearce, GL
Freemantle, SN
Mann, RD
Citation: Fj. Mackay et al., Nefazodone in community use: The results of prescription-event monitoring, PHARMA D S, 8(4), 1999, pp. 267-273
Authors:
Wilton, LV
Pearce, G
Mann, RD
Citation: Lv. Wilton et al., The use of newly marketed drugs in children and adolescents prescribed in general practice. (vol S1, pg S37, 1999), PHARMA D S, 8(4), 1999, pp. 305-305
Authors:
Martin, RM
Wilton, LV
Mann, RD
Citation: Rm. Martin et al., Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: Retrospective analysis of 58 prescription-event monitoring cohort studies, PHARMA D S, 8(3), 1999, pp. 179-189
Authors:
Dunn, N
Freemantle, S
Pearce, G
Wilton, LV
Mann, RD
Citation: N. Dunn et al., Safety profile of nicorandil - Prescription-event monitoring (PEM) study, PHARMA D S, 8(3), 1999, pp. 197-205
Authors:
Wilton, LV
Stephens, MDB
Mann, RD
Citation: Lv. Wilton et al., Interim report on the incidence of visual field defects in patients on long term vigabatrin therapy, PHARMA D S, 8, 1999, pp. S9-S14
Authors:
Wilton, LV
Pearce, G
Mann, RD
Citation: Lv. Wilton et al., The use of newly marketed drugs in children and adolescents prescribed in general practice, PHARMA D S, 8, 1999, pp. S37-S45
Authors:
Mackay, FJ
Dunn, NR
Mann, RD
Citation: Fj. Mackay et al., Antidepressants and the serotonin syndrome in general practice, BR J GEN PR, 49(448), 1999, pp. 871-874
Authors:
Mackay, FR
Dunn, NR
Martin, RM
Pearce, GL
Freemantle, SN
Mann, RD
Citation: Fr. Mackay et al., Newer antidepressants: a comparison of tolerability in general practice, BR J GEN PR, 49(448), 1999, pp. 892-896
Authors:
Wilton, LV
Stephens, MDB
Mann, RD
Citation: Lv. Wilton et al., Visual held defect associated with vigabatrin: observational cohort study, BR MED J, 319(7218), 1999, pp. 1165-1166
Authors:
Dunn, N
Mann, RD
Citation: N. Dunn et Rd. Mann, Prescription-event and other forms of epidemiological monitoring of side-effects in the UK, CLIN EXP AL, 29, 1999, pp. 217-239
Authors:
Mann, RD
Mackay, F
Pearce, G
Freemantle, S
Wilton, LV
Citation: Rd. Mann et al., Losartan: a study of pharmacovigilance data on 14 522 patients, J HUM HYPER, 13(8), 1999, pp. 551-557
Authors:
Dunn, NR
Freemantle, SN
Mann, RD
Citation: Nr. Dunn et al., Cohort study on calcium channel blockers, other cardiovascular agents, andthe prevalence of depression, BR J CL PH, 48(2), 1999, pp. 230-233
Authors:
Mackay, FJ
Pearce, GL
Mann, RD
Citation: Fj. Mackay et al., Cough and angiotensin II receptor antagonists: cause or confounding?, BR J CL PH, 47(1), 1999, pp. 111-114